Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ.

J Cardiovasc Electrophysiol. 2019 Jun;30(6):941-949. doi: 10.1111/jce.13942. Epub 2019 Apr 21.

PMID:
31006943
2.

Calcium/calmodulin-dependent protein kinase II regulation of IKs during sustained β-adrenergic receptor stimulation.

Shugg T, Johnson DE, Shao M, Lai X, Witzmann F, Cummins TR, Rubart-Von-der Lohe M, Hudmon A, Overholser BR.

Heart Rhythm. 2018 Jun;15(6):895-904. doi: 10.1016/j.hrthm.2018.01.024. Epub 2018 Feb 2.

3.

Influence of Oral Progesterone Administration on Drug-Induced QT Interval Lengthening: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Tisdale JE, Jaynes HA, Overholser BR, Sowinski KM, Flockhart DA, Kovacs RJ.

JACC Clin Electrophysiol. 2016 Dec;2(7):765-774. doi: 10.1016/j.jacep.2016.02.015.

4.

Iterative Development and Evaluation of a Pharmacogenomic-Guided Clinical Decision Support System for Warfarin Dosing.

Melton BL, Zillich AJ, Saleem J, Russ AL, Tisdale JE, Overholser BR.

Appl Clin Inform. 2016 Nov 23;7(4):1088-1106.

5.

1-Alpha, 25-dihydroxyvitamin D3 alters the pharmacokinetics of mycophenolic acid in renal transplant recipients by regulating two extrahepatic UDP-glucuronosyltransferases 1A8 and 1A10.

Wang X, Wang H, Shen B, Overholser BR, Cooper BR, Lu Y, Tang H, Zhou C, Sun X, Zhong L, Favus MJ, Decker BS, Liu W, Peng Z.

Transl Res. 2016 Dec;178:54-62.e6. doi: 10.1016/j.trsl.2016.07.006. Epub 2016 Jul 19.

6.

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.

Abdelhady AM, Shugg T, Thong N, Lu JB, Kreutz Y, Jaynes HA, Robarge JD, Tisdale JE, Desta Z, Overholser BR.

J Cardiovasc Electrophysiol. 2016 Oct;27(10):1206-1213. doi: 10.1111/jce.13032. Epub 2016 Jul 25.

7.

Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.

Tisdale JE, Allen MR, Overholser BR, Jaynes HA, Kovacs RJ.

J Cardiovasc Electrophysiol. 2015 Jun;26(6):671-7. doi: 10.1111/jce.12641. Epub 2015 Mar 31.

8.

Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ.

Circ Cardiovasc Qual Outcomes. 2014 May;7(3):381-90. doi: 10.1161/CIRCOUTCOMES.113.000651. Epub 2014 May 6. Erratum in: Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):981.

9.

The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients.

Pergolizzi JV Jr, Ma L, Foster DR, Overholser BR, Sowinski KM, Taylor R Jr, Summers KH.

J Manag Care Spec Pharm. 2014 May;20(5):467-76.

10.

Population pharmacogenetic-based pharmacokinetic modeling of efavirenz, 7-hydroxy- and 8-hydroxyefavirenz.

Abdelhady AM, Desta Z, Jiang F, Yeo CW, Shin JG, Overholser BR.

J Clin Pharmacol. 2014 Jan;54(1):87-96. doi: 10.1002/jcph.208. Epub 2013 Nov 19.

11.

Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.

Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, Kovacs RJ.

Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):479-87. doi: 10.1161/CIRCOUTCOMES.113.000152. Epub 2013 May 28. Erratum in: Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):e57.

12.

Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments.

Mohamed AN, Abdelhady AM, Spencer D, Sowinski KM, Tisdale JE, Overholser BR.

Am J Kidney Dis. 2013 Jun;61(6):1046-8. doi: 10.1053/j.ajkd.2013.02.358. Epub 2013 Apr 4. No abstract available.

13.

Drug-induced atrial fibrillation.

Kaakeh Y, Overholser BR, Lopshire JC, Tisdale JE.

Drugs. 2012 Aug 20;72(12):1617-30. doi: 10.2165/11633140-000000000-00000. Review.

14.

High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis.

Wroblewski HA, Kovacs RJ, Kingery JR, Overholser BR, Tisdale JE.

Antimicrob Agents Chemother. 2012 Aug;56(8):4495-9. doi: 10.1128/AAC.06396-11. Epub 2012 May 21.

15.
16.

Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction.

Tisdale JE, Overholser BR, Wroblewski HA, Sowinski KM, Amankwa K, Borzak S, Kingery JR, Coram R, Zipes DP, Flockhart DA, Kovacs RJ.

J Clin Pharmacol. 2012 Sep;52(9):1296-305. doi: 10.1177/0091270011416939. Epub 2011 Nov 1.

17.

Opioid pharmacokinetic drug-drug interactions.

Overholser BR, Foster DR.

Am J Manag Care. 2011 Sep;17 Suppl 11:S276-87. Review.

18.

A retrospective cohort study of a nurse-driven computerized insulin infusion program versus a paper-based protocol in critically ill patients.

Bouw JW, Campbell N, Hull MA, Juneja R, Guzman O, Overholser BR.

Diabetes Technol Ther. 2012 Feb;14(2):125-30. doi: 10.1089/dia.2011.0130. Epub 2011 Oct 19.

PMID:
22011007
19.

The influence of an elective introductory clinical research course on pharmacy student interest in pursuing research-based careers.

Overholser BR, Foster DR, Henry JR, Plake KS, Sowinski KM.

Am J Pharm Educ. 2010 Nov 10;74(9):165.

20.

The influence of progesterone alone and in combination with estradiol on ventricular action potential duration and triangulation in response to potassium channel inhibition.

Tisdale JE, Overholser BR, Wroblewski HA, Sowinski KM.

J Cardiovasc Electrophysiol. 2011 Mar;22(3):325-31. doi: 10.1111/j.1540-8167.2010.01869.x. Epub 2010 Aug 19.

PMID:
20731743
21.

Sudden death in the presence of overt beta-adrenergic receptor activation in guinea pigs immediately following isoflurane anesthesia.

Overholser BR, Zheng X, Pell C, Blickman A.

Vet Anaesth Analg. 2010 May;37(3):273-9. doi: 10.1111/j.1467-2995.2010.00533.x.

PMID:
20456114
22.

Paroxysmal beta-adrenergic receptor-mediated alterations in ventricular repolarization at rapid heart rates during inhibition of delayed rectifier currents.

Overholser BR, Zheng X, Tisdale JE.

J Cardiovasc Pharmacol. 2009 Sep;54(3):253-62. doi: 10.1097/FJC.0b013e3181b2b706.

PMID:
19620881
23.

Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.

Tisdale JE, Overholser BR, Sowinski KM, Wroblewski HA, Amankwa K, Borzak S, Kingery JR, Coram R, Zipes DP, Flockhart DA, Kovacs RJ.

Pharmacotherapy. 2008 Dec;28(12):1461-70. doi: 10.1592/phco.28.12.1461.

PMID:
19025427
24.

Catecholaminergic effects on ventricular repolarization during inhibition of the rapid component of the delayed rectifier potassium current in a perfused heart model.

Overholser BR, Zheng X, Tisdale JE.

Pharmacotherapy. 2008 Nov;28(11):1315-24. doi: 10.1592/phco.28.11.1315.

PMID:
18956991
25.

Biostatistics primer: part 2.

Overholser BR, Sowinski KM.

Nutr Clin Pract. 2008 Feb;23(1):76-84.

PMID:
18203967
26.

Limited sampling strategies to estimate exposure to the green tea polyphenol, epigallocatechin gallate, in fasting and fed conditions.

Foster DR, Sowinski KM, Chow HH, Overholser BR.

Ther Drug Monit. 2007 Dec;29(6):835-42.

PMID:
18043484
27.

Biostatistics primer: part I.

Overholser BR, Sowinski KM.

Nutr Clin Pract. 2007 Dec;22(6):629-35. Review. Erratum in: Nutr Clin Pract. 2009 Dec;24(6):741.

PMID:
18042950
28.

Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.

Cochran BG, Sowinski KM, Fausel C, Overholser BR.

Am J Health Syst Pharm. 2007 Jul 1;64(13):1410-4.

PMID:
17592007
29.

Development of an efficient sampling strategy to predict enoxaparin pharmacokinetics in stage 5 chronic kidney disease.

Overholser BR, Brophy DF, Sowinski KM.

Ther Drug Monit. 2006 Dec;28(6):807-12.

PMID:
17164698
30.

Gatifloxacin pharmacokinetics in healthy men and women.

Zhang X, Overholser BR, Kays MB, Sowinski KM.

J Clin Pharmacol. 2006 Oct;46(10):1154-62.

PMID:
16988204
31.

Effect of ensure on the oral bioavailability of gatifloxacin in healthy volunteers.

Kays MB, Overholser BR, Lagvankar S, Goldman M, Sowinski KM.

Pharmacotherapy. 2005 Nov;25(11):1530-5.

PMID:
16232015
32.

Pharmacokinetics of intravenously administered levofloxacin in men and women.

Overholser BR, Kays MB, Lagvankar S, Goldman M, Mueller BA, Sowinski KM.

Pharmacotherapy. 2005 Oct;25(10):1310-8.

PMID:
16185174
33.

Sex-related differences in the pharmacokinetics of oral ciprofloxacin.

Overholser BR, Kays MB, Forrest A, Sowinski KM.

J Clin Pharmacol. 2004 Sep;44(9):1012-22.

PMID:
15317829
34.

Effects of sevelamer hydrochloride and calcium acetate on the oral bioavailability of ciprofloxacin.

Kays MB, Overholser BR, Mueller BA, Moe SM, Sowinski KM.

Am J Kidney Dis. 2003 Dec;42(6):1253-9.

PMID:
14655198
35.

Determination of gatifloxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detection.

Overholser BR, Kays MB, Sowinski KM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5;798(1):167-73.

PMID:
14630373

Supplemental Content

Loading ...
Support Center